Insiders · MDGL

Robert E. Waltermire

Senior VP, Chief Pharma Dev. at Madrigal Pharmaceuticals, Inc. (MDGL) since August 2021

Robert E. Waltermire has filed 16 insider reports with the SEC since August 2021, as senior VP and chief Pharma Dev. at Madrigal Pharmaceuticals, Inc. (MDGL). Robert E. Waltermire made no open-market purchases or sales in the last 12 months. In the latest filing, on March 7, 2025, Robert E. Waltermire sold 14,113 shares of Madrigal Pharmaceuticals, Inc. (MDGL) for $4.82M at an average of $341.32.

Filings
16
Companies
1
Bought on market
None
Sold on market
$11.3M

Companies where Robert E. Waltermire is an insider

CompanyRoleShares heldBoughtSoldAvg buyPrice nowLast filing
Madrigal Pharmaceuticals, Inc. logo
MDGL
Madrigal Pharmaceuticals, Inc.
Senior VP, Chief Pharma Dev.since August 20215,789$11.3M$421.99Mar 7, 2025

Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.

Every filing

Compare Robert E. Waltermire with

Other insiders at the same companies

Questions about Robert E. Waltermire

What is Robert E. Waltermire's role at Madrigal Pharmaceuticals, Inc.?
Robert E. Waltermire reports to the SEC as senior VP and chief Pharma Dev. at Madrigal Pharmaceuticals, Inc. (MDGL), according to the latest filing on March 7, 2025.
How many shares does Robert E. Waltermire own?
After the latest filing that states it, Robert E. Waltermire directly owned 5,789 shares of Madrigal Pharmaceuticals, Inc. (MDGL). Shares held through trusts, funds or family members are reported separately and are not counted here.
Has Robert E. Waltermire bought or sold stock recently?
The most recent open-market sale was on March 5, 2025: sold 14,113 shares of Madrigal Pharmaceuticals, Inc. (MDGL) for $4.82M at an average of $341.32.
How do I get alerts when Robert E. Waltermire files?
Follow Robert E. Waltermire on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.

From SEC Forms 3, 4, 5 and 144 filed by Robert E. Waltermire (SEC CIK 0001876996). Totals count each trade once, skipping amendments whose original is on file, from Aug 5, 2021 on. View on SEC EDGAR